Inogen Inc·4

Mar 3, 4:58 PM ET

Ramade Gregoire 4

4 · Inogen Inc · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Inogen (INGN) CCO Gregoire Exercises Derivatives; Shares Withheld

What Happened

  • Ramade Gregoire, Chief Commercial Officer of Inogen (INGN), converted derivative awards into 13,005 common shares (reported as "exercise or conversion of derivative") and had 6,022 shares withheld to cover tax withholding, a reported $36,734 value. The filing also reports a grant/award of 20,000 restricted stock units (RSUs) on Feb 27, 2026. These transactions reflect vesting/conversion activity rather than an open-market buy or sell.

Key Details

  • Transaction dates: RSU grant 2026-02-27; conversions/exercises and withholding 2026-03-01.
  • Reported prices: conversion/exercise reported at $0.00 (derivative conversion); 6,022 shares withheld at $6.10 each for tax withholding (total $36,734).
  • Net immediate shares received (per filing): 13,005 shares acquired via conversion less 6,022 shares withheld = +6,983 shares net added to Gregoire’s holdings (based on the reported entries).
  • Grant detail: 20,000 RSUs reported as granted on 2026-02-27; each RSU represents a contingent right to one share (footnote).
  • Vesting schedule noted: 1/3 of the RSUs vested on March 1, 2026; thereafter 1/3 vests annually on the same date, subject to continued service (footnotes F3–F4).
  • Tax withholding: The 6,022 shares were withheld to satisfy the reporting person’s tax withholding liability in connection with vested time-based RSUs (footnote F1).
  • Filing timeliness: Form 4 was filed 2026-03-03 for transactions on 2/27 and 3/01; this appears to be timely (Form 4s are due within two business days of the reportable transaction).

Context

  • These entries reflect typical executive equity vesting and conversion of RSUs (derivative conversion) rather than a purchase or open-market sale. The withholding of shares to cover taxes is routine and does not necessarily indicate a change in the insider’s view of the company. The reported "exercise/conversion" means derivative awards were converted into common shares; no immediate open-market sale of the remaining shares was reported in this filing.

Insider Transaction Report

Form 4
Period: 2026-02-27
Ramade Gregoire
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-01+13,00550,251 total
  • Tax Payment

    Common Stock

    [F1]
    2026-03-01$6.10/sh6,022$36,73444,229 total
  • Award

    Restricted Stock Unit

    [F2][F3]
    2026-02-27+20,00020,000 total
    Common Stock (20,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F2][F4]
    2026-03-01+13,00526,010 total
    Common Stock (13,005 underlying)
Footnotes (4)
  • [F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2026.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
  • [F3]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2027 (the "2027 Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2027 Vesting Commencement Date.
  • [F4]1/3rd of the restricted stock units vested on March 1, 2026 (the "2026 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2026 Vesting Commencement Date.
Signature
/s/ Mary Wright, as Attorney-in-Fact|2026-03-03

Documents

1 file
  • 4
    ownership.xmlPrimary

    4